Regional Fos expression induced by morphine withdrawal in the 7-day-old rat

Developmental Psychobiology

Volumn 51, Issue 7, 2009, Pages 544-552

  McPhie, Anika A ^a,c   Barr, Gordon A ^a,b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Dependence; Fos; Locus coeruleus; Morphine; Nucleus accumbens; Opiate; Periaqueductal gray; Spinal cord; Withdrawal

Indexed keywords

MORPHINE; PROTEIN FOS;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; LOCUS CERULEUS; MORPHINE ADDICTION; NERVE CELL NETWORK; NONHUMAN; NUCLEUS ACCUMBENS; PERIAQUEDUCTAL GRAY MATTER; PROTEIN EXPRESSION; RAT; SPINAL CORD; WITHDRAWAL SYNDROME;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; CELL COUNT; FEMALE; IMMUNOHISTOCHEMISTRY; LOCUS COERULEUS; MALE; MORPHINE; MORPHINE DEPENDENCE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; NUCLEUS ACCUMBENS; PERIAQUEDUCTAL GRAY; PREGNANCY; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, LONG-EVANS; SPINAL CORD; SUBSTANCE WITHDRAWAL SYNDROME;

RATTUS;

EID: 70350532628     PISSN: 00121630     EISSN: 10982302     Source Type: Journal    
DOI: 10.1002/dev.20392     Document Type: Article

References (72)

1. Adams, M. L., Kalicki, J. M., Meyer, E. R., & Cicero, T. J. (1993). Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, N(G)-nitro-L-arginine methyl ester. Life Sciences, 52, PL245-PL249.
2. Adams, R. E., & Wooten, G. F. (1990). Dependence and withdrawal following intracerebroventricular and systemic morphine administration: Functional anatomy and behavior. Brain Research, 518, 6-10.
3. Aghajanian, G. K. (1978). Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature, 276, 186-188.
4. Akbarian, S., Rios, M., Liu, R.-J., Gold, S. J., Fong, H.-F., Zeiler, S., et al. (2002). Brain-derived neurotrophic factor is essential for opiate-induced plasticity of noradrenergic neurons. Journal of Neuroscience, 22(10), 4153-4162. (Pubitemid 37465722)
5. Anand, K. J., & Arnold, J. H. (1994). Opioid tolerance and dependence in infants and children. Critical Care Medicine, 22, 334-342.
6. Andersen, S. L., LeBlanc, C. J., & Lyss, P. J. (2001). Maturational increases in c-fos expression in the ascending dopamine systems. Synapse, 41(4), 345-350.
7. Barr, G. A., & Goodwin, G. A. (1997). Precipitated morphine withdrawal induces a conditioned aversion in the preweaning rat. Pharmacology Biochemistry and Behavior, 57(4), 779-783.
8. Barr, G. A., & Rossi, G. (1992). Conditioned place preference from ventral tegmental injection of morphine in neonatal rats. Brain Research. Developmental Brain Research, 66, 133-136.
9. Barr, G. A., & Wang, S. (1992). Tolerance and withdrawal to chronic morphine treatment in the week-old rat pup. European Journal of Pharmacology, 215, 35-42.
10. Bhargava, H. N., & Thorat, S. N. (1996). Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome. Pharmacology, 52(2), 86-91.
11. Blasig, J., Herz, A., Reinhold, K., & Zieglgansberger, W. S. (1973). Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacology, 33, 19-38.
12. Boucher, T., Jennings, E., & Fitzgerald, M. (1998). The onset of diffuse noxious inhibitory controls in postnatal rat pups: A C-Fos study. Neuroscience Letters, 257(1), 9-12. (Pubitemid 28546892)
13. Buccafusco, J. J., Terry, A. V., Jr., & Shuster, L. (1995). Spinal NMDA receptor-Nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat. Brain Research, 679, 189-199.
14. Buckett, W. R. (1964). A new test for morphine-like physical dependence (addiction liability) in rats. Psychopharmacology, 4, 410-416.
15. Carlezon, W. A., Boundy, V. A., Haile, C. N., Lane, S. B., Kalb, R. G., Neve, R. L., et al. (1997). Sensitization to morphine induced by viral-mediated gene transfer. Science, 277, 812-814.
16. Chieng, B., Keay, K. A., & Christie, M. J. (1995). Increased fos-like immunoreactivity in the periaqueductal gray of anaesthetised rats during opiate withdrawal. Neuroscience Letters, 183, 79-82.
17. Clancy, B., Darlington, R. B., & Finlay, B. L. (2001). Translating developmental time across mammalian species. Neuroscience, 105(1), 7-17. (Pubitemid 32722089)
18. Delander, G. E., & Takemori, A. E. (1983). Spinal antagonism of tolerance and dependence induced by systemically administered morphine. European Journal of Pharmacology, 94(1-2), 35-42.
19. Donaldson, H. H. (1918). A comparison of growth changes in the nervous system of the rat with corresponding changes in the nervous system of man. Proceedings of the National Academy of Sciences, 4(3), 280-283.
20. Druhan, J. P., Walters, C. L., & Aston-Jones, G. (2000). Behavioral activation induced by D(2)-like receptor stimulation during opiate withdrawal. Journal of Pharmacology and Experimental Therapeutics, 294(2), 531-538.
21. Dworkin, S. I., Guerin, G. F., Goeders, N. E., & Smith, J. E. (1988). Kainic acid lesions of the nucleus accumbens selectively attenuate morphine self-administration. Pharmacology Biochemistry & Behavior, 29, 175-181. (Pubitemid 18052734)
22. Finnegan, L. P. (1985). Effects of materanl opiate abuse on the newborn. Federation Proceedings, 44, 2314-2317.
23. Franck, L. S., Vilardi, J., Durand, D., & Powers, R. (1998). Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation. American Journal of Critical Care, 7(5), 364-369. (Pubitemid 128456927)
24. Frenois, F., Stinus, L., Di Blasi, F., Cador, M., & Le Moine, C. (2005). A specific limbic circuit underlies opiate withdrawal memories. Journal of Neuroscience, 25(6), 1366-1374. (Pubitemid 40250712)
25. Geary, W. A. I., & Wooten, G. F. (1985). Dose effects of naloxone on fixed morphine dependence: Simultaneous behavioral and 2-deoxyglucose study in the rat. Brain Research, 332, 69-78.
26. Geary, W. A. I., &Wooten, G. F. (1986). Time action profiles of regional cerebral glucose utilization during naloxone-precipitated morphine withdrawal. Brain Research, 399, 181-184.
27. Geller, L. M., & Geller, E. S. (1966). A simple technique for permanent marking of newborn albino rats. Psychological Reports, 18, 221-222.
28. Hayward, M. D., Duman, R. S., & Nestler, E. J. (1990). Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brain. Brain Research, 525, 256-266.
29. Hsu, S., Raine, L., & Fanger, H. (1981). Use of avidin- biotinperoxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. Journal of Histochemistry & Cytochemistry, 29, 577-580. (Pubitemid 11147380)
30. Ingram, S. L., Vaughan, C. W., Bagley, E. E., Connor, M., & Christie, M. J. (1998). Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. Journal of Neuroscience, 18(24), 10269-10276. (Pubitemid 29016546)
31. Jones, K. L., & Barr, G. A. (1995). Ontogeny of morphine withdrawal in the rat. Behavioral Neuroscience, 109, 1189-1198.
32. Jones, K. L., & Barr, G. A. (2001). Injections of an opioid antagonist into the locus coeruleus and periaqueductal gray but not the amygdala precipitates morphine withdrawal in the 7-day-old rat. Synapse, 39(2), 139-151.
33. Jones, K. L., Zhu, H., Jenab, S., Du, T., Inturrisi, C. E., & Barr, G. A. (2002). Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959. Neuropsychopharmacology, 26(3), 301-310. (Pubitemid 34159208)
34. Joyce, M. P., & Barr, G. A. (1995). Ontogeny of Fos protein-like immunoreactivity in the suprachiasmatic nucleus. Synapse, 21(1), 54-59.
35. Kimes, A. S., & London, E. D. (1989). Glucose utilization in the rat brain during chronic morphine treatment and naloxone-precipitated morphine withdrawal. Journal of Pharmacology & Experimental Therapeutics, 248, 538-545. (Pubitemid 19090220)
36. Kimes, A. S., Vaupel, D. B., & London, E. D. (1993). Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacology, 112, 521-524.
37. Koob, G. F., & Bloom, F. E. (1988). Cellular and molecular mechanisms of drug dependence. Science, 242, 715-723. (Pubitemid 18276493)
38. Koob, G. F., Wall, T. L., & Bloom, F. E. (1989). Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal. Psychopharmacology, 98, 530-534. (Pubitemid 19193903)
39. Kraft, W. K., Gibson, E., Dysart, K., Damle, V. S., Larusso, J. L., Greenspan, J. S., et al. (2008). Sublingual buprenorphine for treatment of neonatal abstinence syndrome: A randomized trial. Pediatrics, 122(3), e601-e607.
40. Laschka, E., Teschemacher, H. H., Mehraein, P., & Herz, A. (1976). Sites of action of morphine involved in the development of physical dependence in rats. II. Morphine withdrawal precipitated by application of morphine antagonists into restricted parts of the ventricular system and by microinjection into various brain areas. Psychopharmacology, 46, 141-147.
41. Le Guen, S., Catheline, G., & Besson, J. M. (1999). Effects of NMDA receptor antagonists on morphine tolerance: A c-Fos study in the lumbar spinal cord of the rat. European Journal of Pharmacology, 373(1), 1-11. (Pubitemid 29306706)
42. Maeda, T., Kishioka, S., Inoue, N., Shimizu, N., Fukazawa, Y., Ozaki, M., et al. (2002). Naloxone-precipitated morphine withdrawal elicits increases in c-fos mRNA expression in restricted regions of the infant rat brain. Japanese Journal of Pharmacology, 90(3), 270-275. (Pubitemid 35422945)
43. Maldonado, R., Fournié-Zaluski, M. C., & Roques, B. P. (1992). Attenuation of the morphine withdrawal syndrome by inhibition of catabolism of endogenous enkephalins in the periaqueductal gray matter. Naunyn-Schmiedebergs Archives of Pharmacology, 345, 466-472.
44. Maldonado, R., Negus, S., & Koob, G. F. (1992). Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists. Neuropharmacology, 31(12), 1231-1241. (Pubitemid 23002106)
45. Maldonado, R., Stinus, L., Gold, L. H., & Koob, G. F. (1992). Role of different brain structures in the expression of the physical morphine withdrawal syndrome. Journal of Pharmacology and Experimental Therapeutics, 261, 669-677.
46. McPhie, A. A., & Barr, G. A. (2000). The role of opioid receptors in morphine withdrawal in the infant rat [In Process Citation]. Brain Research. Developmental Brain Research, 124(1-2), 73-80.
47. Morgan, J. I., Cohen, D. R., Hempstead, J. L., & Curran, T. (1987). Mapping patterns of c-fos expression in the central nervous system after seizure. Science, 237, 192-197.
48. Osborn, D. A., Cole, M. J., & Jeffery, H. E. (2002). Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database of Systematic Reviews, (3), CD002059.
49. Osborn, D. A., Jeffery, H. E., & Cole, M. J. (2002). Sedatives for opiate withdrawal in newborn infants. Cochrane Database of Systematic Reviews, (3), CD002053.
50. Porterfield, S. P., & Hendrich, C. E. (1993). The role of thyroid hormones in prenatal and neonatal neurological development-current perspectives. Endocrinology Reviews, 14(1), 94-106.
51. Redmond, D. E., & Krystal, J. H. (1984). Multiple mechanisms of withdrawal from opioid drugs. Annual Review of Neuroscience, 7, 443-478.
52. Rohde, D. S., Detweiler, D. J., & Basbaum, A. I. (1996a). Spinal cord mechanisms of opioid tolerance and dependence: Fos-like immunoreactivity expression increases in subpopulations of spinal cord neurons during withdrawal. Neuroscience, 72, 233-242.
53. Rohde, D. S., Detweiler, D. J., & Basbaum, A. I. (1996b). Spinal cord mechanisms of opioid tolerance and dependence: Fos-like immunoreactivity increases in subpopulations of spinal cord neurons during withdrawal [corrected] [published erratum appears in Neuroscience 1996 September; 74(1) 296]. Neuroscience 72(1), 233-242.
54. Romijn, H. J., Hofman, M. A., & Gramsbergen, A. (1991). At what age is the developing cerebral cortex of the rat comparable to that of the full-term newborn human baby? Early Human Development, 26(1), 61-67.
55. Shaw-Lutchman, T. Z., Barrot, M., Wallace, T., Gilden, L., Zachariou, V., Impey, S., et al. (2002). Regional and cellular mapping of cAMP response-element mediated transcription during naltrexone-precipitated morphine withdrawal. Journal of Neuroscience, 22(9), 3663-3672. (Pubitemid 37465771)
56. Stinus, L., Le Moal, M., & Koob, G. F. (1990). Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience, 37, 767-773. (Pubitemid 20282214)
57. Stornetta, R. L., Norton, F. E., & Guyenet, P. G. (1993). Autonomic areas of rat brain exhibit increased fos-like immunoreactivity during opiate withdrawal in rats. Brain Research, 624, 19-28.
58. Thornton, S. R., Wang, A. F., & Smith, F. L. (1997). Characterization of neonatal rat morphine tolerance and dependence. European Journal of Pharmacology, 340, 161-167. (Pubitemid 28022637)
59. Vaughan, C. W., & Christie, M. J. (1997). Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. Journal of Physiology-London, 498, 463-472.
60. Veinante, P., & Freund-Mercier, M. (2003). Branching patterns of central amygdaloid nucleus efferents in the rat: Single-axon reconstructions. Annals of the New York Academy of Sciences, 985, 552-553. (Pubitemid 36521159)
61. Walters, C. L., Aston-Jones, G., & Druhan, J. P. (2000). Expression of fos-related antigens in the nucleus accumbens during opiate withdrawal and their attenuation by a D2 dopamine receptor agonist. Neuropsychopharmacology, 23(3), 307-315. (Pubitemid 30609664)
62. Wiedenmayer, C. P., & Barr, G. A. (2001a). Developmental changes in c-fos expression to an age-specific social stressor in infant rats. Behavioural Brain Research, 126(1-2), 147-157.
63. Wiedenmayer, C. P., & Barr, G. A. (2001b). Developmental changes in responsivity to threat are stimulus-specific in rats. Developmental Psychobiology, 39(1), 1-7.
64. Williams, S., Evan, G., & Hunt, S. P. (1990). Spinal c-fos induction by sensory stimulation in neonatal rats. Neuroscience Letters, 109, 309-314.
65. Windh, R. T., Little, P. J., & Kuhn, C. M. (1995). The ontogeny of mu opiate tolerance and dependence in the rat: Antinociceptive and biochemical studies. Journal of Pharmacology and Experimental Therapeutics, 273(3), 1361-1374.
66. Wise, R. A. (1987). The role of reward pathways in the development of drug dependence. Pharmacology & Therapeutics, 35(1-2), 227-263.
67. Yi, D. K., & Barr, G. A. (1995). The induction of Fos-like immunoreactivity by noxious thermal, mechanical and chemical stimuli in the lumbar spinal cord of infant rats. Pain, 60, 257-265.
68. Yi, D. K., & Barr, G. A. (1997). Formalin-induced c-fos expression in the spinal cord of fetal rats. Pain, 73(3), 347-354. (Pubitemid 28021838)
69. Zhu, H., & Barr, G. A. (2000). Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists. Psychopharmacology (Berlin), 150(3), 325-336. (Pubitemid 30447853)
70. Zhu, H., & Barr, G. A. (2001). Opiate withdrawal during development: Are NMDA receptors indispensable? Trends in Pharmacological Sciences, 22(8), 404-408.
71. Zhu, H., & Barr, G. A. (2003). Ontogeny of NMDA receptor-mediated morphine tolerance in the postnatal rat. Pain, 104(3), 437-447. (Pubitemid 37289043)
72. Zhu, H., & Barr, G. A. (2004). The role of AMPA and metabotropic glutamate receptors on morphine withdrawal in infant rats. International Journal of Developmental Neuroscience, 22(5-6), 379-395. (Pubitemid 39233545)